IPO Details
Issue Date
--
Investment/lot
--
Price Range
--
Lot Size
--
IPO Size
N/A
Schedule of Anlon Healthcare Ltd
Start date
End date
Allotment of bids
Refund Initiation
Listing on exchange
About Anlon Healthcare Ltd IPO
The IPO of Anlon Healthcare Ltd is a 100% book-built offer. It consists entirely of a fresh issue of up to 1,40,00,000 equity Shares.
Objectives of Anlon Healthcare Ltd IPO
The company plans to utilise the proceeds received from the IPO for:
- Funding capital expenditure requirements for expansion of its manufacturing facility
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by it
- Funding the working capital requirements
- Unidentified inorganic acquisitions and general corporate purposes
Anlon Healthcare Ltd IPO Valuation
| Detail | Information |
|---|---|
Upper Price Band | TBA |
Fresh Issue Size | Up to 1,40,00,000 equity shares |
Offer for Sale | NA |
EPS in (₹) for FY 24 | 6.68 |
Anlon Healthcare Ltd IPO Share Offer and Subscription Details
| Investor Category | Shares Offered |
|---|---|
QIBs | Not less than 75% of the issue |
Non-institutional Bidders | Not more than 15% of the issue |
Retail Individual Bidders | Not more than 10% of the issue |
Industry Outlook
Indian pharmaceutical industry is ranked as the third largest in the world, in terms of volumes of drugs manufactured and thirteenth largest, in terms of value. The Indian pharmaceutical industry has witnessed steady growth over the years, contributing approximately 1.72% to the nation's GDP. With an estimated value of ₹4142 billion in FY 2024, the industry is projected to reach ₹7377 billion by FY 2030.
Company Information
Anlon HealthCare Ltd is an R&D driven chemical manufacturing company engaged in manufacturing of pure and advanced pharmaceutical intermediates and active pharmaceutical ingredients. These chemicals serve as the raw material for pharmaceutical formulations, which are then used in various type of finished dosage formula (FDF) such as tablet, capsules, ointment, syrup, etc. ingredients in nutraceuticals formulations, personal care products and animal health products.
Anlon Healthcare Ltd Strengths
Strong product portfolio and scalable business
Anon Healthcare is one of the few manufacturers of loxoprofen sodium dihydrate in India, which is a notable API that is widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.
In addition to the manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, they have also recently started undertaking custom manufacturing services for complex or novel chemical compounds, tailoring the manufacturing process to meet specific customer requirements, including producing chemicals with purity levels that exceed industry standards.
In-house R&D and QA / QC for quality control
The company is a quality and research driven company with continuous efforts focused on quality checks, analysis and developing latest process improvements and production cost efficiencies. Its manufacturing facility has a dedicated QA/QC department and four R&D facilities for testing the raw materials employed in the manufacturing process and the finished products so manufactured along with R&D for developing new products.
Focus on quality, environment, health and safety
In its manufacturing facility, the company has put in place quality check systems that cover areas of its manufacturing process and product delivery, to ensure consistent quality, efficiency and safety of products. Its products go through various quality checks at various stages. They are committed towards quality, environment, health, and safety in pursuant of which they have quality certifications such as ISO9001:2015, GMP, GMP-WHO, HALAL for their Manufacturing Facility.
Risks of Anlon Healthcare Ltd
-
The company is subject to strict technical specifications, quality requirements, regular inspections and audits by its customers or their representatives. Its failure to comply with the quality standards and technical specifications prescribed by such customers may lead to loss of business from such customers and could negatively impact its business, results of operations and financial condition, including cancellation of existing and future orders which may expose it to warranty claims.
-
Its revenue from operations is dependent upon a limited number of customers and the loss of any of these customers or loss of revenue from any of these customers could have a material adverse effect on its business, financial condition, results of operations and cash flows.
-
The company derives a significant portion of its revenue from its operations in India. A reduction in demand for its products in the domestic market could adversely affect its business, results of operations, financial conditions and cash flows.
They operate out of a single manufacturing facility, located at Rajkot, Gujarat which exposes their operations to potential geographical concentration risks arising from local and regional factors which
All Financial Information about Anlon Healthcare Ltd
Particulars (in Rs. crores)
Particulars (in Rs. crores)
Comparison with peers
| Parameter (For FY24) | Anlon Healthcare Ltd | Kronox Lab Sciences Ltd | AMI Organics Ltd | Supriya Lifescience Ltd |
|---|---|---|---|---|
Total Income (in ₹ crore) | 66.6919 | 91.4403 | 701.3687 | 581.005 |
P/E | NA | 31.09 | 128.22 | 42.75 |
Return on Net Worth (in %) | 45.92 | 32.51 | 6.47 | 14.61 |
EPS in ₹ | 6.68 | 5.81 | 11.91 | 14.80 |
IPO Registrar and Book Running Lead Manager
KFin Technologies Ltd is the registrar of this IPO. Interactive Financial Services Ltd is the IPO’s book running lead manager.
Business Model
The company's products span across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. In addition to the manufacturing of pharma intermediate and APIs, the company has recently started undertaking custom manufacturing services for complex or novel chemical compounds, tailoring the manufacturing process to meet specific customer requirements.
Company Growth Trajectory
The company’s net profit margin jumped from (0.19%) in FY 22 to 14.50% in FY 24. Its EBITDA margin jumped from 10.09% in FY 22 to 23.35% in FY 24.
Market Position
In addition to its domestic market sales in India, the company has expanded its scale of operations and global footprint with customers in over 15 countries including Italy, Germany, South Korea, China, Argentina, Chile, Columbia, Mexico, Egypt, Turkey, Japan, Brazil, United Kingdom, United Arab Emirates etc. among others.
Anlon Healthcare Ltd Profit and Loss
| Parameter | FY24 | FY23 | FY22 |
|---|---|---|---|
Total Income (in ₹ crore) | 66.6919 | 113.12 | 57.5364 |
Profit Before Tax (in ₹ crore) | 9.7511 | 6.9932 | (0.1077) |
EBITDA (in ₹ crore) | 15.5694 | 12.6574 | 5.8057 |
EPS in ₹ | 6.68 | 4.85 | (0.09) |
Anlon Healthcare Ltd Cash Flow Statement
| Parameter | FY 24 | FY 23 | FY 22 |
|---|---|---|---|
Profit Before Tax (in ₹ crore) | 9.7511 | 6.9932 | (0.1077) |
Net Cash Flow from Operating Activities (in ₹ crore) | (3.226) | (2.8497) | (1.754) |
Net Cash Flow from Investing Activities (in ₹ crore) | (3.369) | (0.3349) | (0.386) |
Net Cash Flow from Financing Activities (in ₹ crore) | 8.2458 | 2.2659 | 2.8073 |
Cash and Cash Equivalents at the End of the Period (in ₹ crore) | 2.2745 | 0.6236 | 1.5423 |
How to Check Allotment Status of Anlon Healthcare Ltd?
You can check the allotment status of Anlon Healthcare Ltd either through the BSE website or through the registrar’s website. To check the status through BSE website:
- Visit the BSE website
- Click on “Investor Services” and choose “Application Status Check”
- Choose the issue type — Equity or Debt
- Select the Issue Name from the drop-down
- Enter your application number or PAN number
- Check the box that says “I’m not a Robot” and click on “Search” to know the allotment status
To check the status from the registrar’s website:
- Visit the website of KFin Technologies Ltd
- Choose IPO allotment status from “Products’ dropdown
- Click on any of the links
- Select the IPO
- Input either your application number, PAN number or Demat number
- Enter captcha and click on Submit
How to Apply for Anlon Healthcare Ltd IPO?
To apply for this IPO:
- Step 1: Log in to your Kotak Securities Demat account: Log in to your Demat account to access IPO investments. Next, select the current IPO section.
- Step 2: Specify IPO details: Enter the number of lots and the price you wish to apply for.
- Step 3: Enter UPI ID After entering your UPI ID, click submit. This will place your bid with the exchange.
- Step 4: Mandate Notification: Your UPI app will receive a mandate notification to block funds.
- Step 5: Approve Request Your funds will be blocked once you approve the mandate request on your UPI.
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Anlon Healthcare Ltd IPO FAQs
What is the Anlon Healthcare Ltd IPO?
The Anlon Healthcare Ltd IPO is a 100% book-built issue that comprises only a fresh issue of up to 1,40,00,000 equity shares.
What are the bidding dates of Anlon Healthcare Ltd IPO?
The exact dates of the IPO are yet to be announced.
Where can I read about Anlon Healthcare Ltd and its IPO?
You can read about Anlon Healthcare Ltd and its IPO from the company’s draft red herring prospectus here
